Marrow

MARROW FINE, THE CELEBRATED JEWELER, ANNOUNCES THE OPENING OF ITS FIRST FLAGSHIP IN CHICAGO'S GOLD COAST

Retrieved on: 
Thursday, January 18, 2024
SAN, Paseo, Jewellery, One Paseo, Marrow, Ruby, Life

SAN DIEGO, Jan. 18, 2024 /PRNewswire/ -- Marrow Fine, the celebrated fine and bridal jewelry brand whose fans include Margot Robbie, Megan Fox, Machine Gun Kelly, and Richa Moorjani among others, unveils its new showroom in the Gold Coast neighborhood of Chicago, IL with an official opening on Saturday, January 20th. The boutique, the brand's third, is on the ground floor of the exclusive 9 West Walton building.

Key Points: 
  • The boutique, the brand's third, is on the ground floor of the exclusive 9 West Walton building.
  • Known for its signature stacking rings, heirloom reworks and beloved bridal designs, Marrow Fine combines unexpected and playful design elements with serious style.
  • Marrow launched in 2017, and soon after Jillian's husband Tim joined the Marrow team.
  • The duo opened the brand's flagship at One Paseo in Del Mar followed by a second showroom in Newport, Beach, CA.

Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting

Retrieved on: 
Wednesday, July 12, 2023
Osteoporotic bone marrow defect, Theatre, Sports medicine, Surgeon, Ochsner Health System, BMA, Torque, CableACE Award, New York Latin ACE Awards, RSVP, Pain, American Orthopaedic Society for Sports Medicine, Regeneration, Cyst, MD, Patient, Risk, Injury, ACE, Annual general meeting, Marrow, Expert, Joint, Therapy, TSA, Cutting edge, Anika, Video game, Dentistry, Medical imaging

BEDFORD, Mass., July 12, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced it will highlight core products from its joint preservation and restoration portfolio at the 2023 American Orthopaedic Society for Sports Medicine (AOSSM) Annual Meeting on July 13-16th in Washington, D.C. As Anika continues to establish itself as a global market leader in joint preservation, the company will feature its Tactoset Injectable Bone Substitute for hardware augmentation, the X-Twist Fixation System, and the OVOMotion® with Inlay Glenoid Total Shoulder Arthroplasty (TSA) System at booth #311 during the conference.

Key Points: 
  • “We are excited to once again be joining the sports medicine community at the 2023 AOSSM Annual Meeting.
  • Anika’s focused and differentiated product portfolio in sports medicine with regenerative solutions continues to expand to best address the ever-evolving needs of surgeons and their patients.
  • Dr. Misty Suri is scheduled to present his postoperative data on Tactoset during the 2023 AOSSM Annual Meeting.
  • Throughout the 2023 AOSSM Annual Meeting, there will be ample opportunities to learn more about Anika’s featured products at the Anika booth #311 through Ask the Expert sessions.

ReliaQuest Names Colin O’Connor President of Field Operations, Brian Foster President of Product and Technical Operations, and Regina Marrow EVP of Operations

Retrieved on: 
Thursday, April 13, 2023
2023 ReliaQuest Bowl, LLP, ConnectWise Control, Marketing, Neustar, Ernst & Young, CBP Office of Field Operations, Greymatter (software), MobileIron, Intelligence, Zero trust security model, McAfee, Ernst, Marrow, Growth, CIO, Foster, Accenture, Automation, Management, Sales, Operation, Symantec

Colin O’Connor, Chief Operating Officer, is now President of Field Operations, responsible for all sales, marketing and customer success functions at ReliaQuest.

Key Points: 
  • Colin O’Connor, Chief Operating Officer, is now President of Field Operations, responsible for all sales, marketing and customer success functions at ReliaQuest.
  • Brian Foster, Chief Product Officer, is now President of Product and Technical Operations, leading the entire GreyMatter security operations platform team, including product and product management.
  • Additionally, Chief Information Officer Regina Marrow is taking on additional people operations and business functions as CIO and Executive Vice President of Operations.
  • "Regina, Brian, and Colin continue to raise the bar for ReliaQuest and the problem that we solve for our customers around the world.

Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA

Retrieved on: 
Monday, April 3, 2023
Osteoporotic bone marrow defect, American Orthopaedic Society for Sports Medicine, American Sports Medicine Institute, Elective surgery, BMA, HA, Foot, Doctor of Philosophy, Microsoft Exchange Server, Hospital for Special Surgery, Regeneration, Cyst, MD, Patient, Risk, Injury, ACE, Marrow, Biology, Growth, Hospital, FDA, Therapy, Hip, Cutting edge

BEDFORD, Mass., April 03, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has received an additional 510(k) clearance from FDA for Tactoset Injectable Bone Substitute. This new indication expands the use of Tactoset to be combined with autologous bone marrow aspirate (“BMA”). BMA is a rich source of various cellular and molecular components which have demonstrated positive effects on tissue regeneration in musculoskeletal injuries. This increases Tactoset’s commercial reach by combining BMA with Tactoset for the treatment of bone defects such as osteoporotic bone, cysts, and insufficiency fractures.

Key Points: 
  • This increases Tactoset’s commercial reach by combining BMA with Tactoset for the treatment of bone defects such as osteoporotic bone, cysts, and insufficiency fractures.
  • Tactoset is an injectable, settable, calcium phosphate-based bone graft substitute that incorporates Anika’s core hyaluronic acid (HA) technology.
  • Once injected, Tactoset hardens and mimics the properties of normal trabecular bone initially before remodeling into healthy bone over time.
  • To that end, Anika has signed an agreement to distribute the Marrow Cellution Bone Marrow Aspiration Needle in the U.S.

ReliaQuest Names Mike McPherson as Senior Vice President of Security Operations and Regina Marrow as Chief Information Officer

Retrieved on: 
Thursday, May 19, 2022
Internet, Risk, CPA, Telemetry, XDR, Boys & Girls Club, State bureau of investigation, Marrow, Federal Bureau of Investigation, Ernst, United States Coast Guard Academy, CISA, Risk management, Architecture, McPherson, LLP, Accenture, Communication, ISACA, University, Gaps, FBI, Greymatter (software), CFO, Growth, Special agent, CEO, Ernst & Young, Certified Public Accountant, GLOBE, Management, Public relations, Science, Central Florida

Mike McPherson was named as senior vice president of security operations to lead ReliaQuests global security operations team.

Key Points: 
  • Mike McPherson was named as senior vice president of security operations to lead ReliaQuests global security operations team.
  • Regina Marrow joined the company as its chief information officer responsible for ReliaQuests global internal systems, digital transformation, infrastructure and technology initiatives.
  • Regina and Mike bring deep subject matter expertise and knowledge to ReliaQuest fueling our long-term growth and focus on customer outcomes.
  • ReliaQuest, the force multiplier of security operations, increases visibility, reduces complexity, and manages risk with its cloud native security operations platform, GreyMatter.

Marrow Access Technologies Announces the Full US Market Release of the SmartShot® Marrow Access Device

Retrieved on: 
Wednesday, July 7, 2021
Marvel Comics characters, Orthopedic surgery, Marrow, Fictional characters

NASHVILLE, Tenn., July 7, 2021 /PRNewswire/ -- Today at the American Orthopaedic Society for Sports Medicine annual meeting, Marrow Access Technologies announced full US market release of the SmartShot Marrow Access Device.

Key Points: 
  • NASHVILLE, Tenn., July 7, 2021 /PRNewswire/ -- Today at the American Orthopaedic Society for Sports Medicine annual meeting, Marrow Access Technologies announced full US market release of the SmartShot Marrow Access Device.
  • During limited market release, SmartShot was used to treat hundreds of patients suffering from orthopedic injuries, including applications in the knee, shoulder, ankle, hip, and elbow.
  • Marrow Access Technologies and the SmartShot Marrow Access Device are registered trademarks of Marrow Access Technologies.
  • For more information on the SmartShot Marrow Access Device: marrowaccess.com
    View original content to download multimedia: https://www.prnewswire.com/news-releases/marrow-access-technologies-anno...

Witness a father’s love for his son in ‘Life Marrow’

Retrieved on: 
Thursday, October 1, 2020
Fictional characters, Marvel Comics characters, Marrow, Storm

When his 2-year-young son, Lucas Writer, was going through a battle with cancer, his wife, Emily Writer (35-year-old), left him in the most painful stage of his life.

Key Points: 
  • When his 2-year-young son, Lucas Writer, was going through a battle with cancer, his wife, Emily Writer (35-year-old), left him in the most painful stage of his life.
  • Life Marrow begins with the family enjoying the playfulness of their little cheerful two-year-young son.
  • Shocking news followed by relationship breakdown hit their life like a storm and made life difficult for them.
  • Life Marrow is available for purchase online on Balboa Press website at: https://www.balboapress.com/en-au/bookstore/bookdetails/810729-life-marrow .

Incyte Partners with Artist and Patient J.G. Jones to Raise Awareness for Myeloproliferative Neoplasms (MPNs)

Retrieved on: 
Thursday, February 27, 2020
Biotechnology, Other Health, Health, Philanthropy, General Health, Pharmaceutical, Arts, Museums, Entertainment, Oncology, Other Philanthropy, Infectious diseases, Myeloproliferative neoplasm, .NET Framework, Push technology, Microsoft Push Notification Service, MPN, Methylphosphonate synthase, Tumors of the hematopoietic and lymphoid tissues, Marrow, Myeloproliferative Neoplasms, Incyte

View the full release here: https://www.businesswire.com/news/home/20200227005127/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200227005127/en/
    As part of ongoing efforts to raise awareness of MPNs, Incyte has partnered with J.G.
  • Jones, a renowned comic book artist who was diagnosed with an MPN over a decade ago, to capture the experiences of those impacted by MPNs.
  • The illustrations can be viewed at www.VoicesofMPN.com/RareReflections , along with more information about Jones disease journey and the stories of others living with MPNs.
  • Myeloproliferative neoplasms (MPNs) are a closely related group of blood cancers in which the bone marrow functions abnormally.

Finding Heroes and Making Friends in Unexpected Places

Retrieved on: 
Tuesday, December 3, 2019
Medical specialties, Medicine, Branches of biology, Stem cells, Hematology, Bone marrow, Hematopoiesis, Skeletal system, Marrow, Organ transplantation, R (B) v Cambridge Health Authority, Hematopoietic stem cell transplantation

For two little boys in the medical center's Bone Marrow Transplant unit, KJ is much more.

Key Points: 
  • For two little boys in the medical center's Bone Marrow Transplant unit, KJ is much more.
  • He's a cherished friend who helped make their lives in the hospital brighter and more fulfilling.
  • Find out how in the accompanying video, which showcases how sometimes healthcare heroes can come from unexpected places.
  • Now the boys have become friends who will hopefully get the chance to play together when they both get out of the hospital.